Literature DB >> 1864907

Rubella-specific IgG1 avidity: a comparison of methods.

H I Thomas1, P Morgan-Capner.   

Abstract

Two methods of determining the avidity of specific IgG1 were compared with sera from different categories of rubella infection. Both methods were based on an antiglobulin enzyme-linked immunosorbent assay. In one method the absorbances were compared with and without diethylamine (DEA) in the serum diluent over a range of serum dilutions and the difference between the dilution curves measured (DEA-shift). In the other, the absorbances at a single serum dilution were compared with and without urea in the wash fluid used after the antigen/serum incubation (avidity index). Various concentrations of DEA were also assessed in the avidity-index method, as this method is simpler to perform. The DEA-shift method was shown to be more sensitive for diagnosing recent primary rubella or immunization by demonstrating specific IgG1 of low avidity. The avidity-index method, however, was more specific when sera from cases of reinfection or non-specific rubella IgM reactivity were tested. 35 mM DEA was found to be the optimal concentration of DEA when DEA was substituted for urea in the avidity index method.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864907     DOI: 10.1016/0166-0934(91)90160-2

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  6 in total

1.  Reliability of low-avidity IgG and of IgA in the diagnosis of primary infection by rubella virus with adaptation of a commercial test.

Authors:  J Gutiérrez; M J Rodríguez; F De Ory; G Piédrola; M C Maroto
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 2.  Interpretation of rubella serology in pregnancy--pitfalls and problems.

Authors:  Jennifer M Best; Siobhan O'Shea; Graham Tipples; Nicholas Davies; Saleh M Al-Khusaiby; Amanda Krause; Louise M Hesketh; Li Jin; Gisela Enders
Journal:  BMJ       Date:  2002-07-20

3.  Evaluation of commercial rubella immunoglobulin G avidity assays.

Authors:  Samira Mubareka; Hannah Richards; Michael Gray; Graham A Tipples
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

4.  Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.

Authors:  K S Cole; J L Rowles; B A Jagerski; M Murphey-Corb; T Unangst; J E Clements; J Robinson; M S Wyand; R C Desrosiers; R C Montelaro
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.

Authors:  D Chargelegue; C M O'Toole; B T Colvin
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

6.  Humoral immune response to primary rubella virus infection.

Authors:  Kim M Wilson; Carlie Di Camillo; Larissa Doughty; Elizabeth M Dax
Journal:  Clin Vaccine Immunol       Date:  2006-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.